Home LiteratureArticle Details
PMID: 16989988 Published · ppublish English Journal Article

Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating.

Schreiber R, Vivian J, Hedley L, Szczepanski K, Secchi RL, Zuzow M, van Laarhoven S, Moreau JL, Martin JR, Sik A, Blokland A

Abstract

Serotonin(6) (5-HT(6)) receptors are almost exclusively located in the central nervous system. High expression in the hippocampus, nucleus accumbens and striatum is consistent with a potential role in cognition and psychosis. The availability of potent, selective and brain-penetrating 5-HT(6) antagonists such as RO4368554 allows further characterization of the role of the 5-HT(6) receptor in these processes. Herein, we tested RO4368554 in several cognition tasks, as well as sensorimotor gating tests. Using scopolamine-impaired and unimpaired adult male rats, RO4368554 was given in novel object discrimination, social recognition, social discrimination, Morris water maze, passive avoidance and autoshaping procedures. RO4368554 reversed the effects of scopolamine in novel object discrimination (active doses in mg/kg, i.p., 3, 10), social recognition (3, 10), social discrimination (1, 3, 10) and passive avoidance (10, 30 i.p. and 100 p.o.) tasks. In unimpaired rats, RO4368554 enhanced object discrimination (3, 10; 4-h forgetting interval) and autoshaping learning (3), but was inactive in a water maze task (doses tested: 1-10 mg/kg, i.p.). In tests sensitive to antipsychotics, RO4368554 did not reverse sensorimotor gating deficits induced by the psychostimulants dizocilpine and amphetamine (doses tested: 1-30 mg/kg, i.p.) or neonatal lesion of the ventral hippocampus (1-10 mg/kg, i.p.). In conclusion, RO4368554 enhanced learning and memory processes in unimpaired and scopolamine-impaired rats, supporting the notion that the cognitive enhancing effects of 5-HT(6) receptor antagonists involve modulation of cholinergic neurotransmission.

MeSH Terms
Acoustic Stimulation Analysis of Variance Animals Cognition/drug effects Disease Models, Animal Dose-Response Relationship, Drug Drug Interactions Gait Disorders, Neurologic/chemically induced,drug therapy Hippocampus/drug effects,injuries,physiopathology Indoles/pharmacology,therapeutic use Inhibition, Psychological Male Maze Learning/drug effects Neuropsychological Tests Piperazines/pharmacology,therapeutic use Rats Rats, Sprague-Dawley Rats, Wistar Reaction Time/drug effects Reflex, Startle/drug effects Scopolamine Serotonin Antagonists/pharmacology,therapeutic use Social Behavior
Chemicals
Indoles Piperazines Ro4368554 Serotonin Antagonists Scopolamine
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Schreiber Rudy
Pharmacology, Discovery Group, Sepracor, Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752-7010, USA. rudy.schreiber@sepracor.com
Vivian Jef
Hedley Linda
Szczepanski Krystine
Secchi Rob L
Zuzow Marcus
van Laarhoven Susanne
Moreau Jean-Luc
Martin James R
Sik Ayhan
Blokland Arjan
Article Info
Journal
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Abbr.
Eur Neuropsychopharmacol
ISSN
0924-977X
Published
2007-03-00
Epub
2006-00-20
Pages
277-88
Language
English
Region
Netherlands
NLM ID
9111390
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com